The first report of X-linked mental retardation correlated with the presence of marker chromosome came in 1940. It was in 1990 that the molecular basis of fragile X syndrome was deciphered. This elucidation marked the discovery of a novel process of mutation designated as dynamic mutations, resulting in the expansion of a triplet repeat sequence within the human genome. Subsequently several human genetic disorders involving triplet repeat expansion have beer= discovered. Almost all the disorders are known to affect the nervous system and/or the brain. This review presents an overview of fragile sites in the genome and the molecular genetics of fragile X syndrome.
BrdU-inducible
The clinically significant fragile sites that have been characterised are FRAXA, FRA11B and FRAXE. FRA11B is located in the 5' untranslated region of a gene designated, CBL2 oncogene. Fragility is seen in some carrier mothers whose progeny are affected with mental retardation and malformation condition as in Jacobsen's syndrome. In some cases the fragile sites result in deletion of the chromosome fragment distal to the locus; for example, Jacobsen syndrome is a clinical condition that occurs due to the deletion of a part of FRA1A  FRA1B  FRA1C  FRA1L  FRA1D  FRAIM  FRA1E  FRA1J  FRA1F  FRA1G  FRA1K  FRA1H  FRAll  FRA2C  FRA2D  FRA2E  FRA2L  FRA2A  FRA2B  FRA2F  FRA2K  FRA2G  FRA2H  FRA21  FRA2J  FRA3A  FRA3B  FRA3D  FRA3C  FRA4A  FRA4D  FRA4B  FRA4E  FRA4C  FRA5E  FRA5A  FRA5B  FRA5D  FRA5G  FRA6B  =FRA6A  FRA6C   1 the long arm of the chromosome 11 and the deletion breakpoints in some cases are at or very close to the fragile site. This is the only known autosomal fragile site associated with a syndrome (4). Another fragile site FRA16A is detected without any phenotypic association. FRAXA is associated with fragile-X syndrome ,the most common cause of inherited mental retardation next to Down syndrome in frequency of occurrence. The frequency of occurrence is estimated to be 1 in 1000 -2500 births (5). FRAXE is located 600bp distal to FRAXA. Both FRAXA and FRAXE are folate sensitive fragile sites at Xq27.3 and Xq28 respectively. Cytologically these two are indistinguishable from each other. The incidence of FRAXE associated MR appears to be 4% of mental retardation (MR) due to FRAXA i.e., 1/50,000 (6). There is still a great deal of uncertainty about a genotype-phenotype relationship in FRAXEassociated .MR and this is mainly due to the mild phenotypic effect, low incidence and low detection of new FRAXE cases from large candidate population studies (6).
The presence of another fragile site distal to FRAXE was demonstrated by fluorescence in situ hybridisation (FISH) analysis using cosmid probes close to iduronate sulphatase gene at Xq28, 600 kb distal to FRAXE locus (7). The inheritance of the fragile site at the FRAXF locus does not correlate with the presence of mental impairment. One of the well studied systems is the fragile sites on the X chromosome at Xq27and 28: mainly because of the high incidence of mental retardation. The following sections of the review will discuss the molecular and medical genetics of fragility of the X chromosome.
THE CHARACTERIZATION OF A FRAGILE X INDUCTION SYSTEM
It was discovered by Sutherland in 1977 (1) that a folate deficient culture medium was necessary to induce fragile site at Xq27.3. Folate is a onecarbon donor in nucleotide biosynthesis.and its deficiency results in altered thymidine pool within the cell. Excess or deficient thymidine seems to interfere with the DNA helicity. It was seen that the antimetabolite FudR interferes with thymidylate synthase activity by limiting or blocking the formation of TMP from UMP. Increasing the thymidine concentration by including methotrexate and FudR also induces fragile sites. In order to unambiguously visualize the fragile site most laboratories use multiple induction system, specifically 'a double induction' that includes both FudR and thymidine (8). Autism is a severe developmental disorder that is characterised by marked social deficits, delay in language development and a restricted range of stereotyped repetitive behaviour. The ratio of affected males to females is 4:1. The precise cause of autism and the mode of transmission is unknown but it does not follow the classical Mendelian inheritance. Several disorders of known genetic aetiology have been reported to be associated with autism. Among these, fragile X linked mental retardation is the most common. The incidence of the association of fragile-X with autism ranges from 14% or less to 47% (14, 15) .
CAUSES OF FRAGILE X SYNDROME
Genetic linkage studies as well as the analysis of,somatic cell hybrids that carry the fragile X chromosome in a rodent background has shown that the mutation leading to fragile-X syndrome is cis-acting and located at or very close to the fragile site. Subsequently the discovery of a CpG island, a land mark for protein coding sequences, was followed by the identification of an unstable region containing the CGG triplet repeat. Further studies revealed the occurrence of the CGG triplet repeat at the 5' untranslated region (UTR) of a gene which was designated as fragile-X mental retardation, FMR-1 (Fig 1) . The most prevalent cause of the fragile X syndrome is the expansion of the CGG triplet at the 5'untranslated region of FMR-1. The size of the CGG repeat is between 1 and 50 in normal individuals while in patients it can be greater than 200. In a range between 50 and 200 the allele becomes unstable and has a high probability of expansion to greaters than 200 repeats in the next generation. The syndrome itself seems to be manifested due to a tack of expression of the functional Fragile X Menta! Retardation Protein (FMRP). The causative role of FMR1 gene in fragile X syndrome has been confirmed by the detection of deletions and point mutation in the gene from patients suffering from mental retardation and a clinical phenotype similar to the fragile X syndrome. So far the mutations reported at the locus range from deletions of small but critical regions to deletions resulting in removal of the entire gene sequence (16, 17, 18) , small insertions and deletions that lead to loss of function of FMR-1 (19) . Point mutation leading to conversion of isoleucine to aspartic acid that results in Iossof function of FMR-1 lead to fragile -X syndrome (20) . Molecular Study of FRAXE has shown that the fragility is due to an amplification of a GCC repeat adjacent to a CpG island. A candidate gene, FMR2 was identified by the positional cloning. FMR2 was confirmed as the FRAXE-associated gene when cytogenetically positive individuals with 100% methylation of the FRAXE CpG island were feund to have transcriptional silencing (21) . As far as the repeat expansions are concerned, in FRAXA there are three distinct status of repeat, a normal 5-50, a premutation 50-200 and a full mutation range of >200 copies while in the case of FRAXE, a normal range of 4-39 repeats directly seems to expand to a level of around 150-180 copies associated with mild mental impairment along with speech and learning difficulty
FRAGILE X MENTAL RETARDATION PROTEIN (FMRP)
The FMR1 gene consists of 17 exons spanning 38kb of the genome and the corresponding 4.8 kb transcript is alternatively spliced resulting in several isoforms of the protein. Northern blot analysis of RNA from several human tissues indicated the presence of a 4.8kb FMR1 mRNA. The sequence predicts a full-length protein of 614. amino acids with an expected mass of 69 kDa (22) . Antibodies against the human FMRP, fragile X mental retardation protein detected the presence of a similar protein expressed in mice in a wide variety of tissues, particularly in brain, testes, ovaries, thymus, oesophagus and spleen (23) . Moderate to low levels have been detected in kidney, liver, colon, uterus, thyroid and lung. No FMRP was detected in muscle, heart and aorta. FMRP is highly conserved among vertebrates. The human FMRP exhibits 97% homology to the murine protein and early mouse embryos exhibited an enrichment of FMRP in brain and gonads. There are several interesting points about its expression pattern. Immunostaining experiments have shown that FMRP is expressed intensely in nucleus basatis, magnocetlularis and hippocampus. These are centres for cholinergic innervation for cortical and limbic development and control motivation, learning, memory and behaviour (24) . RNA in situ hybridizations have shown that markedly enhanced expression is found in Type A1 spermatogonia. Expression in the fetal testis is observed and it reaches the highest level in immature testis and declines early in adult life. In the mature ovary no FMR1 expression signal is found but enhanced levels were seen in fetal ovary (25) .FMR1 expression studied in primary culture of epithelial cells derived from young mouse kidney shows maximum levels when the cells reach the quiescent G O stage, signifying terminally differentiated cells. However, the FMR1 transcript levels decrease suggesting a post-transcriptional autoregulatory mechanism. When the same cells are transformed with SV40 and the proliferation is resumed, a significant increase in FMRP levels is detected (23) . Transgenic mouse model carrying FMRP fused with lac Z showed strong staining patterns in interstitial cells and leydig cells of the testis and granulosa cells of the ovarian follicles and adrenal cortex-all the cell types that are involved in androgen biosynthesis (26) .Thus the pattern of expression of FMR1 gene closely correlates with the tissues or organs whose function is affected in the diseased state. However the exact function of FMRP is not known. In a fragile X patient with an expansion of the CGG repeat stalling of the 40s ribosomal subunit occurs during scanning prior to the translational initiation because of the extensive potential secondary structure of the GC rich sequence. Hence no functional FMRP is expressed and the FMR1 transcription is also down regulated (27) .
In all the tissues in a normal individual FMRP localizes to the cytoplasm. The exact function of the protein is not known, but it shares extensive homology with certain proteins containing RNA binding domain such as the Rev protein of HIV, hnRNPA1, a protein found Ubiquitously and two autosomal proteins FXR1 and FXR2. FMR-1 forms a heteromer with FXR 1 and FXR2 (28) . About 4% of all the mRNAs in fetal tissues is bound by FMRR Apart from the RNA binding domains, FMRP has a N-terminal KKXKP, a nuc, lear localization signal (NLS) and a 17 amino acid sequence in the exon 14 that is a nuclear export signal (NES). The isoform resulting from alternative splicing of exon 14 lacking the nuclear export signal localizes in the nucleus. So under physiological conditions the NES (also known as the Cytoplasmic Retention Signal) seems to override the effects of NLS. Since FMRP possesses both the NLS and NES, it is proposed to be involved in nucleocytoplasmic transport (29) . Any mechanism such as point mutation that leads to impaired FMR1 function results in an imbalance in the nucleocytoplasmic shuttle. A hypothesis explaining the probable function of FMR1 is that it might be involved in binding RNA transcripts within the nucleus and transporting them across the nuclear membrane for translation in the cytoplasm. In the Case of the point mutation in addition to its inability to bind effectively to the transcripts generated, the mutant FMRP forms abnormally small mRNP particles which fail to be transported across the nucleus and therefore are not selected for translation (30) . The fact that FMR1 is expressed in actively dividing cells, cosediments with 60s ribosomes and strongly interacts with Rab40, a protein found in the nuclear pores seem to support its postulated function (31) . FMRP also interacts with the autosomal proteins with identical RNA binding motifs, FXR1 and FXR2, The non-lethal effects of the lack of FMR1 may be due to the redundancy of its function (28) .
INHERITANCE OF FRAGILE X SYNDROME
Fragile X Syndrome is an X-linked disorder but has an unusual pattern of inheritance (Fig 2) . The general features of the inheritance pattern is known from the analysis of over 200 pedigrees (32) . It deviates from the Mendelian pattern of inheritance such that about 30% of the carrier females are mentally retarded although they are often less severely affected than males. There are two groups of affected individuals, a) a population of around 20% males and females who carry the mutation but do not manifest any phenotypic effects. These are the non-transmitting males. Female progeny of the non-transmitting males also turn out to be carrier females. b) individuals, predominantly males who inherit the mutation from the carrier mothers and manifest the clinical effects of the syndrome.
In normal transmitting males and their daughters no fragile site at Xq27.3 is detected. Thus the disease phenotype itself is found in the offspring only after the transmission of mutation through a female. In other words the syndrome exhibits 'skipping of generation', along with 'genetic anticipation', i.e., the severity of the disease increases in subsequent generation. Collectively these unusual attributes are referred to as 'Sherman Paradox'.
A typical pedigree for fragile X syndrome is depicted in fig 2. The variability in the degree of mental impairment in females and the existence of males who are not affected but pass on the fragile X gene indicates a complex pattern of heredity. Taken into consideration, all the observations, fragile X syndrome is described as an X linked dominant disorder with incomplete penetrance.
IMPRINTING AND FRAGILE -X SYNDROME
The existence of mentally normal males who can transmit the mutation to their daughters who again are asymtomatic and the observation that only grandsons of the non-transmitting males (NTM) are affected at high frequency has led to the hypothesis that fragile -X syndrome might be a two step process involving an imprinting mechanism (34) . Genomic imprinting is a mechanism in which there is non-equivalence of the parental genetic contribution to the progeny which leads to differential expression of homologous genes. The discovery of expansion of CGG rerpeats at the 5' untranslated region of FMR1 gene as the most common molecular basis of fragile -X syndrome and the establishment of three distinct states of the alleles corresponding normal,carrier and full mutation has provided an explanation for some of the unusual attributes of the genetics of fragile X syndrome. Consistent with X inactivation model the expansion seems to occur only when the premutation allele is passaged through meiosis in the female germ line. Inappropriate methytation and unusual DNA structure are proposed as possible explanation for the imprinting phenomenon. However, the exact mechanism of the repeat expansion and the late replication of fragile X locus still remain elusive.
FudR alone(6). In India cytogenetic analysis in low folate media has been the main course of induction to visualize the fragile X syndrome (36) .
DIAGNOSIS OF THE FRAGILE X SYNDROME
Cytogenetic testing was one of the most common tools used for the diagnosis of Fragile X syndrome. Whole blood from the patient is seeded in a folic acid deficient medium and the lymphocytes are cultured for 72 hours. The lymphocytes are further processed and the metaphase spreads are stained and examined for the fragile site at Xq27.3 (Fig3) (35) . The frequency of a fragile X chromosome observed in the karyotypes of males positive for fragile X syndrome varies from 4 to 40% (1) However the variability and subtlety of the classical phenotypic features along with the peculiar inheritance pattern lowers the chances of recognising the fragile site. To increase the reliability of the detection, more than one method of induction, such as FudR, Thy and Methotrexate induction is used. Such a combination or the most often used 'double induction' system consisting of FudR and Thy was found to exhibit marginal high frequencies of fragile X expression. However this also proved to be unreliable since more often than not the cultures oscillated between poor growth in thymidine containing medium to about 5 times higher expression of fragile site in media with Though cytogenetic testing is done on a routine basis it is highly unreliable because not all the cells in an affected male exhibits the fragile site, both transmitting males and carrier females have no abnormality and a significant percentage of the carrier females are cytogenetically normal. It is also tedious and unreliable for prenatal diagnosis. During the 1980, linkage analysis with DNA markers close to the fragile X locus was used in conjunction with the cytogenetic analysis for prenatal diagnosis and genetic counselling in families with the fragile X syndrome. But such analysis requires the testing for many markers not to mention the availability of informative families. The situation is also complicated by recombination involving the fragile X locus. All things considered molecular diagnosis with the use ofa DNA probe mapping at FMR1 gene proved to be the most reliable and direct method in both the carriers of the fragile X syndrome as well as the affected individuals, regardless of their sex (37) . It is also reliable and applicable for prenatal diagnosis.
Cloning of the 5'UTR of FMR-1 and its further characterisation has resulted in the discovery of the Fig.,3: A representative metaphase plate showing fragile site at Xq27.3 from a patient. On southern analysis his DNA from this patient was found to have a CGG repeat number of around 600.
CpG island upstream of the (CGG) repeat loci. In premutations (CGG)n where n=50-200 and full mutation where n>200 abnormal methylation of the CpG island is detected. Using restriction enzymes that are inhibited by DNA methylation it is possible to detect the sequences that are abnormally methylated on the X chromosome in females that can be distinguished from the fragments corresponding to the premutation or the normal sequence which remain unmethylated only on the active X chromosome. Direct diagnosis of the fragile X syndrome by the digestion with restriction endonucleases such as EcoRI, Hindlll, Pstl and Bcll has greatly improved the chances of detection of fragile X syndrome (37) . These enzymes can cleave the DNA sequences on either side of the region where CGG repeat is present. Therefore the length of the fragment derived from this region of the FMR 1 gene will vary depending upon the number of the CGG repeats present (Fig 4) . By Southern hybridization, using probes derived from sequences 3' or 5' to the (CGG) repeat that are part of the larger fragments large deletions involving CGG repeat and flanking sequences as well as the methylation status of the FMR1 in an individual can be detected (37) .
Reagents for DNA based analysis of the FMR1 have been generated and utilised in the diagnosis of fragile-X patients and analysis of polymorphism at the FMR1 allele in the Indian population (38) . Southern blotting are inconvienient when large number of individuals have to be tested for fragile X syndrome. The use of monoclonal antibodies against FMRP offers a rapid means to discriminate the normal from the affected individuals. However detection of the borderline premutation status that does not affect the expression cannot be detected (39) . Point mutations leading to the manifestation of the syndrome can be detected by amplifying the exons of FMR1 by PCR followed by sequencing the PCR product.
ANIMAL MODELS
The FMR1 gene is highly conserved among the species and the murine homolog, fmrl shows almost 97% homology at the amino acid sequence level. The expression pattern of FMR 1 at the mRNA and the protein level is very similar in different tissues of humans and mice. Mouse also has the CGG repeat stretch at the 5'UTR though the repeat numbers show .no polymorphism (40, 41) . This makes mouse a good model system to study fragile X syndrome. The initial attempts to create a mouse model for fragile X syndrome was the FMR1 knockout mice. The knock out mice lack the normal Fmr-1 RNA and protein and show enlarged testes, impaired cognitive function and aberrant behaviour reflecting the phenotype exhibited by affected individuals (42) . Three independent attempts have been made to create mouse models carrying the trinucleotide repeat sequences. Transgenic mice with [(CGG)22TGG(CGG)43TGG(CGG)2,] (43) transmitted the sequence without detectable changes.Transgenic mice containing 32, 76 and 120 triplets including 9, 53 or 97 uninterrupted CGGs respectively at the 3' end of the repeat array were created. Analysis of the repeat stretch upto 4 generations showed that there was no difference in the size from the microinjected construct (44) . Transgenic mouse models carrying the repeat sequences even in premutation range showed no instability. This suggests that apart from being a human-specific phenomenon, the position of the interruptions, the flanking sequences and several other factors relating to the genome organisation influence the repeat expansion. Taking genome organisation of the human FMR1 into consideration, recently a mouse model for repeat expansion has been generated. This transgenic system shows limited intergenerational instability of the CGG repeats (41) . The utility of the model system is immense in resolving certain unique attributes of the fragile X syndrome. For instance the developmental timing of repeat expansion is debated due to the occurrence of monozygotic twin pairs showing discordant repeat numbers at FMR1 locus (41, 45) on one hand and the results with abortuses from fragile X patients which showed full mutation alleles suggesting that expansions are perhaps prezygotic event and that the variability in repeat number occurs during early embryonic divisions (46) .
CONCLUDING SECTION
Among the normal population the polymorphic CGG repeat varying between 6-50 is interspersed with one to three single AGG sequence approximately every 10 CGG repeat. The AGG sequence is proposed to have an anchoring effect on the repeat sequence and to confer stability. Point mutations in the AGG interspersion could result in sequence configurations which lack AGG or have just one AGG interspersion as in (CGG)9 AGG(CGG). Such sequences with a rare AGG interspersion towards the 3' end are considered to be predisposed towards replication slippage. Additionally there seems to be a strong association between long (CGG) repeats at the 3' end of the AGG interspersion with configurations such as (CGG)9 AGG(CGG)>_20, (CGG)10 AGG(CGG)>2o and their tendency to assume premutation status. Such alleles are also called protomutations (47) . These obsevations have led to the hypothesis that imperfections within repeats are responsible for stabilizing the size of the repeat and the absence of imperfections contributes to the instability and the repeat expansion. The molecular mechanism resulting in triplet repeat mutational expansions are still unclear. A working hypothesis regarding the evolution of fragile X full mutations can be defined in the following 4 stages (57). Initial occurrence of ancestral events leading to the formation of predisposing alleles which have large total repeat length (e.g. between 35-50) but no AGG or one AGG interspersion. This event could be the point mutation leading to the loss of AGG, a gradual slippage of these predisposing alleles to small premutations (S alleles), followed by conversion from S alleles to larger premutations (Z). Finally, the Z alleles can undergo massive expansions to form full mutation (L) alleles,resulting in fragile X syndrome.Evidence for this hypothesis comes from the fact that PCR amplification of the CGG repeat region in the normal control as well as the premutation alleles followed by sequence analysis shows the highest variability of the pure repeat lengths among the controls occuring at the 3' end. In one of the studies all the premutation alleles showed _>50 pure CGG repeats while a majority of the controls hardly had _> 40 repeats (28) .
The discovery of molecular basis of several neurological disorders highlight the functional potential of repetitive sequences in the genome. The high degree of polymorphism in such sequences seen in the population has been effectively utilised in molecular genetic analysis of human genome and its functions. This is also important in deciphering the genetic basis of variability in phenotypes between individuals; even in such simple phenotypes as levels of hemoglobin. Thus the molecular basis of fragile X syndrome has drawn attention to the importance of untranslated sequences within genes in disease processes. The knowledge gained over the last decade has contributed greatly to fundamental biology and the fragile X syndrome in particular, however the therapeutic value of this knowledge is still to be fully perceived and practiced. The immediate application would be restricted to prenatal diagnosis and genetic counseling. Therapy in terms of gene replacement or intervention in disease causing mutations is presently at an entirely academic level. It is important to note that a beginning at therapy at the primary level cannot even be contemplated if the molecular anatomy of the disease is unknown. 
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